NUTEX HEALTH INC. (NUTX) FY2026 Q2 P&L / Income Statement

NUTEX HEALTH INC. (NUTX) FY2026 Q2 P&L / Income Statement

Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenue

210,752,000 US dollars

Cost of revenue (calculated)

69,473,000 US dollars

Gross profit

141,279,000 US dollars

Total corporate and other costs

19,561,000 US dollars

Operating income

121,718,000 US dollars

Other income (expense), net (calculated)

negative 4,633,000 US dollars

Income before taxes

117,085,000 US dollars

Income tax expense

20,768,000 US dollars

Net income

96,317,000 US dollars

Hospital division

201,852,000 US dollars

Population health management division

8,900,000 US dollars

Total operating costs and expenses

69,473,000 US dollars

Stock-based compensation

2,884,000 US dollars

General and administrative expenses

16,677,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
• Of which attributable to NUTEX HEALTH INC.: $65.84 M; to noncontrolling interests: $30.48 M.